HIV News and Research

RSS

FDA approval of raltegravir offers new weapon to treat HIV infection in children

For children and adolescents with HIV infection, the recent Food and Drug Administration (FDA) approval of the use of raltegravir, an antiretroviral drug that slows the spread of HIV infection, offers a new weapon to treat HIV infection in children.

7 Jan 2012

UNC HIV researcher Cohen discusses his work, HPTN 052

PSI's "Healthy Lives" blog features a video from the UNC Medical Center News Office in which Myron Cohen, a professor of medicine, microbiology, immunology and public health at the University of North Carolina-Chapel Hill and the director of the Institute for Global Health and Infectious Diseases, discusses his research into HIV/AIDS prevention, including his lead role in HPTN 052.

6 Jan 2012

New HIV vaccine candidates show promise in monkeys

"The quest for a vaccine against AIDS is gaining momentum, with research published Wednesday identifying promising new candidates that protected monkeys against a powerful strain of the virus and that soon could be tested in humans," the Wall Street Journal reports.

6 Jan 2012

British Columbia's 'treatment-as-prevention strategy' helping to reduce HIV/AIDS cases, deaths

"New HIV cases and AIDS deaths are both going steadily down in British Columbia, according to data released last week," the New York Times reports.

6 Jan 2012

Novel vaccine combinations can protect against infection by SIV

Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.

5 Jan 2012

Doctors may need to adjust seizure drug doses for people with HIV/AIDS: New AAN guideline

A new guideline issued by the American Academy of Neurology recommends doctors use caution when choosing seizure drugs for people with HIV/AIDS to avoid potential drug interactions.

5 Jan 2012

Ethiopia's PMTCT plan needs men to participate in order to reach goal, experts say

"Ethiopia's new plan to eliminate mother-to-child HIV transmission by 2015 cannot be attained unless men are more meaningfully involved in reproductive health, experts say," PlusNews reports.

5 Jan 2012

Investigational HSV vaccine shows promise against two genital herpes diseases

An investigational vaccine protected some women against infection from one of the two types of herpes simplex viruses that cause genital herpes, according to findings in the New England Journal of Medicine.

5 Jan 2012

Study reveals factors associated with prevention, control of HIV infection

New vaccine research in monkeys suggests that scientists are homing in on the critical ingredients of a protective HIV vaccine and identifies new HIV vaccine candidates to test in human clinical trials.

5 Jan 2012

Viewpoints: Sebelius on 'essential benefits'; WSJ columnist on Democrats' 'Mediscare' argument - is it a lie?

Insurance needs and health systems vary state to state, and experience tells us that the best way forward is not to mandate a one-size-fits-all answer. Instead, our approach gives states the flexibility to take their own paths, while ensuring they all end up in the best place possible: with an Affordable Insurance Exchange that offers access to comprehensive, quality, affordable health insurance to small business owners and individuals who currently have few good choices in an expensive and broken market.

5 Jan 2012

Scientists determine structure of endomannosidase enzyme

Scientists have determined the structure of the enzyme endomannosidase, significantly advancing our understanding of how a group of devastating human viruses including HIV and Hepatitis C hijack human enzymes to reproduce and cause disease.

4 Jan 2012

Working in Kazakhstan to end HIV stigma, discrimination

In this post on USAID's "IMPACTblog," Erin McKee, USAID mission director for the Central Asian Republics, recounts a discussion roundtable with people "on the front lines" in the battle against HIV/AIDS in Kazakhstan.

4 Jan 2012

PlusNews highlights 10 major HIV headlines of 2011

In a year-end recap of 10 major HIV-related headlines, PlusNews writes, "It's been a roller coaster of a year in HIV and AIDS. AIDS turned 30 in 2011, and with new evidence of the effectiveness of HIV treatment as prevention, experts are increasingly talking about 'the end of AIDS.'

4 Jan 2012

State Department fact sheets examine cholera, food security, health progress in Haiti

The State Department has released a series of fact sheets examining the U.S. government's two-year progress in Haiti. One fact sheet examines government efforts to "lessen the severity of the cholera outbreak" in Haiti.

4 Jan 2012

J&J will not join Medicines Patent Pool; Company's pharma head says mechanism could 'cause disaster'

Pharmaceutical company "Johnson & Johnson has rejected calls to offer patent rights on its HIV medicines to generic drug companies through a" Medicines Patent Pool, created to promote low-cost antiretroviral drugs in low-income countries and the development of new drug combinations and formulations, the Financial Times reports.

4 Jan 2012

Woman's ovarian cycle plays an important role in her susceptibility to infection

A new research report in the Journal of Leukocyte Biology suggests that a woman's ovarian cycle plays an important role in her susceptibility to infection.

4 Jan 2012

Similar sounding drug names should come with warnings

There have been mix ups and medication errors with similar sounding names of drugs - eye drops called Durezol and salicylic acid-containing wart remedy Duresal for example.

1 Jan 2012

Drinking untreated water increases risk of mycobacterial infection

Infections caused by mycobacteria (bacteria which are the cause of diseases such as tuberculosis in humans and animals) have a great impact on public health, animal health and the health of ecosystems in rural areas of Uganda.

29 Dec 2011

Bali tattoo and HIV transmission scare

Tourists who have gotten themselves tattooed or pierced whilst in Bali are being warned to seek medical advice after a Western Australian man reportedly contracted HIV during a recent holiday trip.

28 Dec 2011

Critical considerations for adenovirus-based HIV vaccine trials

A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work. Moreover, subsequent analyses indicated that the vaccine made some individuals more susceptible to HIV, in particular individuals who had pre-existing immune effectors (antibodies) that recognized a component of the vaccine (adenovirus serotype 5 [Ad5]).

28 Dec 2011

HIV News and Research

FDA approval of raltegravir offers new weapon to treat HIV infection in children

UNC HIV researcher Cohen discusses his work, HPTN 052

New HIV vaccine candidates show promise in monkeys

British Columbia's 'treatment-as-prevention strategy' helping to reduce HIV/AIDS cases, deaths

Novel vaccine combinations can protect against infection by SIV

Doctors may need to adjust seizure drug doses for people with HIV/AIDS: New AAN guideline

Ethiopia's PMTCT plan needs men to participate in order to reach goal, experts say

Investigational HSV vaccine shows promise against two genital herpes diseases

Study reveals factors associated with prevention, control of HIV infection

Viewpoints: Sebelius on 'essential benefits'; WSJ columnist on Democrats' 'Mediscare' argument - is it a lie?

Scientists determine structure of endomannosidase enzyme

Working in Kazakhstan to end HIV stigma, discrimination

PlusNews highlights 10 major HIV headlines of 2011

State Department fact sheets examine cholera, food security, health progress in Haiti

J&J will not join Medicines Patent Pool; Company's pharma head says mechanism could 'cause disaster'

Woman's ovarian cycle plays an important role in her susceptibility to infection

Similar sounding drug names should come with warnings

Drinking untreated water increases risk of mycobacterial infection

Bali tattoo and HIV transmission scare

Critical considerations for adenovirus-based HIV vaccine trials

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News